Market Alert: Global Equity Markets Under Pressure Amid Valuation Concerns and Economic Uncertainty
HITIQ Limited (ASX:HIQ) has announced that Monash University has secured an Australian Research Council (ARC) Discovery Project grant worth AU$799,866, featuring HITIQ’s PROTEQT™ instrumented mouthguard technology. Under the program, HITIQ will supply 400 PROTEQT™ units in January 2026, generating AU$200,000 in revenue.
The study will combine biomechanics and biomarkers to establish measurable thresholds for brain injury risk, supporting the development of global concussion management standards. The project positions PROTEQT™ as a leading research tool for objective head impact measurement.
Executive Chair Earl Eddings said the collaboration validates HITIQ’s technology and provides vital clinical evidence for regulatory pathways and commercial adoption. The initiative reinforces HITIQ’s leadership in sports safety innovation, combining real-time head impact analytics with medical research to better understand and prevent brain injuries.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Nov 06, 2025
Nov 06, 2025
Nov 06, 2025
Nov 06, 2025
Nov 06, 2025
Nov 06, 2025
Nov 06, 2025
Nov 06, 2025
Nov 06, 2025
Nov 06, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.